ISDS Case Map
CPTPP
Comprehensive and Progressive Agreement for Trans-Pacific Partnership
The trade ministers of Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, United States, and Vietnam, have successfully concluded the Trans-Pacific Partnership.
Australia — along with others such as New Zealand and Chile — has been unwilling to offer more than five years protection for the medicines, because longer terms would increase the cost of state-subsidised medical programs.
Countries in the trade bloc would have an alternative of either providing eight years of exclusivity to biologic drugs, or providing five years of so-called data exclusivity plus up to three more years under a regulatory framework in the TPP.
Vietnam has tentatively agreed with the United States on a fully enforceable implementation plan to bring its labor regime into compliance with the Trans-Pacific Partnership.
TPP negotiators hope to finalize the agreement in the next few days. Political leaders will boast of promoting the well-being of their people and countries. But the reality is that special interests have been given far too much influence on the negotiations.
A standoff between Australia and the United States on monopoly rules forpharmaceutical drugs has emerged as the ultimate impediment to clinching anhistoric trade deal sweeping across 12 Pacific Rim countries.
SOEs are Malaysia’s toughest issue in the TPP negotiations.
The latest round of Trade and Investment Framework Agreement (TIFA) talks with the US ignores the interests of ordinary citizens, labor activists said yesterday.
The new exception validates, rather than assuages, the concerns of those who have been criticizing ISDS systems for many years. Without express carve outs, ISDS provisions do threaten common health and safety regulations.
Dairy farmers from around Ottawa took their cows and tractors to Parliament Hill this week, to protest the changes they expect in the Trans-Pacific Partnership trade deal.
